Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 04/30/2019 (updated monthly) $1,131.6 (M)
Net Assets - Advisor ClassAs of 04/30/2019 (updated monthly) $154.0 (M)
P/E Ratio (12-mo Forward)As of 04/30/2019 (updated monthly) 14.85
P/B RatioAs of 04/30/2019 (updated monthly) 5.36

Positions As of 04/30/2019

Number of Issuers 84

All Retail Fund Holdings Reports

Portfolio Details

Asset AllocationAs of 04/30/2019

[name] [value]
Equity 97.67%
Cash & Cash Equivalents 2.33%

Geographic BreakdownAs of 04/30/2019

No chart available for this data.
[name] [value]
United States 86.50%
United Kingdom 3.90%
Netherlands 2.59%
Denmark 2.54%
Cash & Cash Equivalents 2.33%
Canada 0.74%
Germany 0.60%
Switzerland 0.59%
Israel 0.22%

sector breakdownAs of 04/30/2019

[name] [value]
Biotechnology 77.95%
Pharmaceuticals 14.65%
Life Sciences Tools & Services 5.07%
Cash & Cash Equivalents 2.33%

TOP TEN HOLDINGSAs of 04/30/2019

44.87%
Other
0% 100%
[holdings-table-heading]
ALEXION PHARMACEUTICALS INC 7.20%
VERTEX PHARMACEUTICALS INC 5.31%
ARRAY BIOPHARMA INC 5.28%
ILLUMINA INC 5.07%
BIOGEN INC 4.09%
GW PHARMACEUTICALS PLC 3.90%
REGENERON PHARMACEUTICALS INC 3.79%
GILEAD SCIENCES INC 3.59%
BIOMARIN PHARMACEUTICAL INC 3.34%
AMGEN INC 3.30%

You need Adobe Acrobat Reader 6.0 or higher to view and print PDF documents. Download a free version from Adobe's website.